The subsidiary of AS PRFoods (registry code 11560713) Saaremere Kala AS (registry code 11310040, hereinafter "Seller") signed an agreement on 05.12.2025 for the sale of its 100% shareholding in Saare Kala Tootmine OÜ (registry code 10377013, hereinafter "SKT") and transfer of claims arising from shareholder loans and an inventory loan provided to SKT to the Latvian company Brīvais Vilnis A/S (Latvian registry code: 40003056186, hereinafter "Buyer"). SKT engages in the production and sale of fish products. I ...

Aspo Plc ANNOUNCEMENT 5.12.2025 Aspo Plc: Share repurchase 5.12.2025 In the Helsinki Stock Exchange Trade date 5.12.2025 Bourse trade Buy Share ASPO Amount 3 000SharesAverage price/ share 6,6573EURTotal cost 19 971,90EUR Aspo Plc now holds a t ...

Core Points - A meeting of the creditors of AUGA group was held on December 3, 2025, to form a Creditors' Committee and define its functions [1] - The restructuring plan of the Company was approved, leading to the appointment of 5 members to the Creditors' Committee [1] Group 1: Creditors' Committee Composition - The Creditors' Committee includes two largest secured creditors, two representatives of other creditors' groups, and a representative of employees' interests [1] - Uždaroji akcinė bendrovė "Urbo bankas" was nominated as the third largest representative of other creditors' group after BIGBANK AS declined to participate [1] Group 2: Committee Members - The Chairperson of the Creditors' Committee is from Komanditinė ūkinė bendrija "Pagalbos verslui fondas" [2] - Laurynas Miškinis represents employees' interests [2] - Uždaroji akcinė bendrovė "Okseta" represents creditors whose claims are secured by pledge and/or mortgage [2] - Akciju sabiedriba "Citadele banka" Lietuvos filialas and Uždaroji akcinė bendrovė "Urbo bankas" represent other creditors' groups [2]

As announced by AUGA group, AB, legal entity code 126264360 undergoing restructuring, legal entity code 126264360 (hereinafter – the Company) in its material event notice dated 20 January 2025, its wholly controlled subsidiary UAB ‚ AWG investment 1’ (hereinafter – the Issuer) has issued private bonds, ISIN LT0000409104, with a total nominal value of EUR 4,984,000 (hereinafter – the Bonds). The Issuer undertook to redeem the Bonds and pay the accrued but unpaid interest by 8 November 2025. Since the redempt ...

ABSECON, N.J., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Absecon Bancorp (the “Company”) (OTC, trading as ASCN), the bank holding company of First National Bank of Absecon, an Atlantic County New Jersey based community bank, announced today that its Board of Directors declared a regular quarterly cash dividend in the amount of $1.05 per share, payable on December 30, 2025 to shareholders of record as of December 16, 2025. The First National Bank of Absecon, a nationally chartered bank headquartered in Absecon, New ...

CARLSBAD, Calif., Dec. 05, 2025 (GLOBE NEWSWIRE) -- Aptera Motors (Nasdaq: SEV) announced today that Co-CEO Chris Anthony will participate in A.G.P.’s Annual Virtual Electric Vehicles and Transportation Conference on December 9, 2025. The event is hosted by A.G.P./Alliance Global Partners. A.G.P.’s Capital Markets team works closely with portfolio managers of hedge funds, mutual funds, and registered investment advisors. Chris Anthony will deliver an investor presentation as part of the conference program. ...

Copenhagen Airports A/S hereby announces that the company has today received the attached notice from the Kingdom of Denmark via the Ministry of Finance. The notice reminds the shareholders of Copenhagen Airports A/S that the offer period for the mandatory tender offer submitted by the Kingdom of Denmark, via the Ministry of Finance, expires on 10 December 2025 at 11:59 p.m. (CET). Attachments Company announcement reminding of the expiry of the offer period for the mandatory tender offer Reminder of m ...

Core Insights - Gelteq Limited has announced preclinical findings that demonstrate the effectiveness, flexibility, and safety of its proprietary gel-based oral delivery systems, addressing significant challenges in pharmaceutical development [1][6]. Preclinical Study Results - Two preclinical studies showed a 300% increase in bioavailability of an oil-soluble compound in Gelteq's gel base compared to an existing FDA-approved reference product within the first hour, which is critical for rapid onset of action [2]. - Overall absorption of the oil-soluble compound improved by more than 20% over 24 hours when using Gelteq's gel base compared to the reference product [3]. - The gel platform enables controlled movement through the digestive system, targeted release, and effective absorption while ensuring full clearance of both the active pharmaceutical ingredients and the gel material [4]. Mechanism of Action - The gel disperses the active ingredient uniformly along the small intestine, enhancing absorption through mucoadhesive interactions and presenting the drug across a larger intestinal surface area [5]. - The gel's structural matrix allows for efficient transit and rapid early absorption of the active pharmaceutical ingredient, reinforcing its safety and compatibility with oral administration [6]. Industry Context - Over 40% of approved drugs and up to 90% of developmental candidates face issues with poor solubility and bioavailability, leading to significant annual investments in new technologies to address these challenges [7]. - Gelteq's platform offers a streamlined solution that may reduce developmental burdens, enhance bioavailability, and potentially revive previously shelved or challenging molecules [7]. Therapeutic Applications - Therapeutic areas likely to benefit from Gelteq's gel-based delivery system include neurology, inflammation and pain management, hormonal therapies, cardiovascular medicine, nutraceuticals, weight management, oncology, and veterinary health, where lipid-based or poorly soluble APIs are common [8]. Strategic Positioning - By enabling consistent absorption, targeted delivery, reduced reliance on excipients, and strong safety characteristics, Gelteq positions itself as a valuable development partner for pharmaceutical and nutraceutical companies looking to reformulate existing assets or tackle complex formulation challenges [9].

Exclusive on Amazon.com, December 2–15, 2025 — Flagship 4K laser and portable projectors with up to 47.4% off for Christmas movies, gaming and holiday sports NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) -- Dangbei, a leading innovator in smart projection technology, is bringing big-screen Christmas magic to U.S. homes with a series of limited-time deals on Amazon.com. From December 2 to December 15, 2025, shoppers can save up to 47.4% and as much as $900 on selected 4K home cinema and portable projectors. From ...

DECLARATION DU NOMBRE D’ACTIONS COMPOSANT LE CAPITALET DU NOMBRE TOTAL DE DROITS DE VOTE AU 30 NOVEMBRE 2025 Article L. 233-8-II du Code de CommerceArticle 223-16 du Règlement général de l’AMF Nombre d’actions composant le capital social237 553 695Nombre de droits de vote théoriques287 011 643Nombre de droits de vote exerçables282 190 807 Cette déclaration est en ligne sur le site internet d’Elis www.elis.com DISCLOSURE OF THE NUMBER OF SHARES FORMING THE CAPITALAND OF THE TOTAL NUMBER OF VOTING RIGHTS AS O ...